Table 2.
Patient characteristics | % (n) | HAD total mean ± SE | Treatment factors | n (%) | HAD total mean ± SE |
---|---|---|---|---|---|
Marital status | Current Treatment | ||||
Married | 75.9 (79) | 13.17 ± 7.87 | Tamoxifen | 47.1 (49) | 13.65 ± 8.30 |
Single | 24 (25) | 19.12 ± 10.47 | Aromatase inhibitors (AI) | 52.9 (55) | 15.45 ± 9.37 |
MWU = 704, p = 0.031 | MWU = 1223, p = 0.417 | ||||
Children | Duration of AET | ||||
One or More | 82.7 (86) | 14.36 ± 8.53 | Between 1 and 24 months | 49 (51) | 16.01 ± 9.19 |
None | 17.3 (18) | 15.77 ± 10.60 | Between 25 and 58 months | 51 (53) | 13.24 ± 8.45 |
MWU = 761, p = 0.911 | MWU = 1073, p = 0.070 | ||||
Education | Pathological tumor stage | ||||
Primary or secondary | 33.7 (35) | 18.68 ± 9.57 | T1 | 40.4 (42) | 15.40 ± 9.28 |
High school | 32.7 (34) | 12.38 ± 7.23 | T2 | 51 (53) | 14.30 ± 8.83 |
College or above | 33.7 (35) | 12.68 ± 8.43 | T3 | 8.7 (9) | 12.66 ± 7.77 |
KW = 9.489, p = 0.009 | KW = 0.589, p = 0.745 | ||||
Body mass index | Histological grade | ||||
≤24.99 | 31.7 (33) | 12.48 ± 7.12 | Grade I | 11.5 (12) | 12.91 ± 9.11 |
25–29.9 | 40.4 (42) | 14.33 ± 9.65 | Grade II | 49 (51) | 15.60 ± 8.98 |
≥30 | 27.9 (29) | 17.41 ± 9.08 | Grade III | 39.4 (41) | 13.85 ± 8.77 |
KW = 4.188, p = 0.123 | KW = 1.750, p = 0.417 | ||||
Menopausal status | Type of surgery | ||||
Pre-menopausal | 46.2 (48) | 13.50 ± 8.43 | Mastectomy | 56.7 (59) | 14.66 ± 8.76 |
Peri or post-menopausal | 53.8 (56) | 15.55 ± 9.23 | Breast conserving surgery | 43.3 (45) | 14.53 ± 9.14 |
MWU = 1194, p = 0.329 | MWU = 1308, p = 0.901 | ||||
Socioeconomic status | Radiotherapy | ||||
Low | 17.3 (18) | 16.05 ± 10.11 | Yes/no | 71.2 (74)/28.8 (30) | 14.97 ± 8.97/13.70 ± 8.75 |
Middle | 70.2 (73) | 14.24 ± 8.69 | MWU = 1020, p = 0.520 | ||
High | 12.5 (13) | 14.61 ± 8.73 | Chemotherapy | ||
KW = 0.512, p = 0.774 | Yes/no | 61.5 (64)/38.5 (40) | 15.21 ± 9.02/13.62 ± 8.69 | ||
MWU = 1129, p = 0.314 |
MWU Mann–Whitney U, KW Kruskall Wallis